Table 2. Bivariate Cox regression of symptom resolution predictors by type of variant of concern.
| Delta | Omicron | |||
|---|---|---|---|---|
| Predictor | HR (95% CI) | p value |
HR
(95% CI) |
p value |
| Gender | 0.80 (0.57–1.11) |
0.182 | 0.84 (0.61–1.14) |
0.257 |
| Age | 1.00 (0.98–1.02) |
0.952 | 1.00 (0.98–1.01) |
0.626 |
| BMI | 1.03 (0.72–1.50) |
0.855 | 1.17 (0.82–1.68) |
0.393 |
| SARS-CoV-2 serological status | 0.93 (0.67–1.31) |
0.690 | 0.82 (0.57–1.20) |
0.307 |
| Anti-SARS-CoV-2 vaccination status | 1.30 (0.83–2.04) |
0.257 | 0.91 (0.66–1.24) |
0.539 |
| Diabetes | 0.63 (0.34–1.18) |
0.150 | 1.19 (0.76–1.88) |
0.444 |
| Cardiovascular disease | 0.96 (0.69–1.35) |
0.831 | 0.85 (0.62–1.17) |
0.319 |
| Chronic kidney disease | 1.24 (0.58–2.66) |
0.581 | 1.12 (0.57–2.21) |
0.733 |
| Chronic liver disease | 2.42 (0.76–7.68) |
0.135 | 1.33 (0.74–2.40) |
0.341 |
| Chronic pulmonary disease | 0.78 (0.46–1.31) |
0.346 | 0.98 (0.67–1.43) |
0.902 |
| Immunocompromising conditions | 1.00 (0.60–1.66) |
0.989 | 0.80 (0.55–1.17) |
0.252 |